EW - Edwards Lifesciences Corporation

NYSE - NYSE Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue3,722,8003,435,3002,963,7002,493,700
Cost of Revenue939,400875,300797,400617,200
Gross Profit2,783,4002,560,0002,166,3001,876,500
Operating Expenses
Research Development622,200552,600442,200382,900
Selling General and Administrative1,088,600996,500904,700850,700
Non Recurring----
Others-700700700
Total Operating Expenses2,650,2002,425,1002,144,3001,850,800
Operating Income or Loss1,072,6001,010,200819,400642,900
Income from Continuing Operations
Total Other Income/Expenses Net-311,20024,700-81,500-20,500
Earnings Before Interest and Taxes1,072,6001,010,200819,400642,900
Interest Expense-29,900-23,200-19,200-17,200
Income Before Tax761,4001,034,900737,900622,400
Income Tax Expense39,200451,300168,400127,500
Minority Interest----
Net Income From Continuing Ops722,200583,600569,500494,900
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income722,200583,600569,500494,900
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares722,200583,600569,500494,900